HenLin mainly undertakes the production and research of medical intermediates - namely 2,6-dichlorotoluene, 2,6- dichlorobenzaldehyde, 2-chloro,6-fluoro.benzaldoxime, cloxacillin sodium dicloxacillin sodium, flucloxacillin sodium and 1-chlororthyl ethyl carbonate and 4-pyridyl mercaptoacetyl chloridehy drochloride etc.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Contact information




View All Contact Info

Top Products


Hengshui Henglin Biotech Co Ltd

Categories affiliated with Hengshui Henglin Biotech Co Ltd